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Abstract. Background: Oral tongue squamous cell carcinoma
(OTSCC) cells are highly proliferative and invasive.
Lingonberry contains several polyphenolic compounds similar
to curcumin. We hypothesize that fermented lingonberry juice
(FLJ) has an anti-invasive and anti-proliferative effect on
OTSCC cells similarly to curcumin, which is known to be anti-
carcinogenic. Materials and Methods: FLJ, curcumin dissolved
in ethanol, or curcumin loaded in Candida extracellular
vesicles (EVs) were added to more (HSC-3) and less aggressive
(SCC-25) OTSCC cells. Cell proliferation was measured with
a 5-bromo-2’-deoxyuridine kit and invasion in the three-
dimensional Myogel spheroid assay. Statistical analyses were
completed with one-way ANOVA and Bonferroni post-hoc
testing. Results: Both FLJ and curcumin significantly reduced
the proliferation and invasion of HSC-3 and SCC-25 cells. The
effects of curcumin were not improved when cells were treated
with curcumin loaded within EVs. Conclusion: Our results
suggest that FLJ, like curcumin, has an anti-carcinogenic effect
on aggressive OTSCC cells in vitro.
Oral cancer is the tenth most common cancer in men
worldwide, and most of these cancers are oral tongue
squamous cell carcinomas (OTSCCs). Bioactive protective
anticancer molecules are present in a healthy diet containing
high amounts of fruits and vegetables (1). Pavia et al.
showed a ~50% reduction in oral cancer risk for each portion
of fruit or vegetable consumed per day (2). Similar results
for reducing the risk of head and neck cancer by fruits and
vegetables was documented by Freedman et al. (3).
Berries from the genus Vaccinium, such as blueberry (V.
corymbosum), cranberry (V. macrocarpon), bilberry (V. myrtillus
L.) and lingonberry (V. vitis-idaea), have several health benefits.
They positively affect gut microbiota and cardiovascular disease
outcomes and negatively affect tumour growth (4). When
cloudberries (Rubus chamaemorus) or lingonberries were added
to a modified high-fat diet in mice, the number and size of
colonic adenomas were significantly reduced, demonstrating the
tumour-preventative capacities of these berries (5). Similarly, a
decrease in lung metastasis of breast cancer by fermented
blueberries was documented in a mouse model by Vuong et al.
(6). Tsuda et al. analysed five Vaccinium species in vitro and
observed that the one with the highest total polyphenol content
had the greatest anti-proliferative and pro-apoptotic effects on
the pro-myelocytic human leukaemia cell line HL-60 (7).
However, to the best of our knowledge, the effects of fermented
lingonberry juice (FLJ) on OTSCC proliferation and invasion
have not been studied.
Curcumin is the phenolic component of turmeric (Curcuma
longa), and although used in Chinese and Indian medicine, it
is still mainly applied as a spice. It has antimicrobial,
hepatoprotective, cardioprotective, thrombosuppressive, and
anti-carcinogenic properties, including inhibitory effects on
OTSCC cells (8, 9). Recently, curcumin was shown to reduce
oral squamous cell carcinoma cell migration at low doses
(10), as well as the invasiveness of an OTSCC cell line, SCC-
25 (11). A phase I clinical trial reported histological
improvement in precancerous lesions after treatment with
curcumin for 3 months in 29% of patients who had high risk
of cancer transformation (12). The poor bioavailability of
curcumin has shifted focus towards loading curcumin into
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vehicles, such as nanoparticles and liposomes (9). Saengkrit
et al. loaded cationic liposomes with curcumin (13), Dhule et
al. used a 2-hydroxypropyl-γ-cyclodextrin/curcumin liposome
complex (14) and later introduced nanoliposomes containing
phospholipids, chitosan and curcumin (15). Instead of using
synthetic carriers, Aqil et al. loaded curcumin into
extracellular vesicles (EVs) isolated from bovine milk (16).
In this study, we aimed to evaluate the anti-proliferative
and anti-invasive properties of FLJ on OTSCC cell lines and
compare the effects to those of curcumin. Curcumin was
either dissolved in ethanol or combined with EVs isolated
from Candida glabrata.
Materials and Methods
Chemicals. Curcumin was obtained from Sigma-Aldrich (St Louis,
MO, USA). A stock solution of 5 mg curcumin per ml 70% ethanol
was prepared. Locally produced lingonberry juice (0.1 g/ml) was
fermented using the yeast Saccharomyces cerevisiae as described
by Pärnänen (17).
Isolation and characterization of EVs. C. glabrata G212 (clinical
strain; Helsinki University Central Hospital, Finland) was cultivated
on Sabouraud agar and incubated overnight at 37˚C before being
transferred into Sabouraud broth, which was incubated on a shaker
(120 rpm) for 48 h at 37˚C.
EVs were isolated using a two-step ultracentrifugation procedure.
Firstly, the broth was filtered (0.22 μm) then centrifuged at 11 000 × g
for 30 min at 4˚C. The supernatant was collected and centrifuged again
at 100 000 × g for 90 min at 4˚C. The second supernatant was
discarded and the pellet containing EVs was resuspended in 300 μl
phosphate-buffered saline (PBS) and kept at −80˚C until further use.
Purified EVs were analysed by nanoparticle tracking analysis (NTA)
using a NanoSight LM14 viewing unit (NanoSight, Salisbury, UK)
equipped with a blue (404 nm, 70 mW) laser and scientific CMOS
camera. The samples were diluted in Dulbecco’s PBS and three videos
of 90 s were recorded using camera level 14. The data were analysed
using NTA software version 3.0 (NanoSight) with the detection
threshold optimized for each sample and the screen gain at 10 to track
as many particles as possible with minimal background. The EV
content of C. glabrata G212 was 3.5×106 EVs/μl PBS.
EVs were spiked with 30 μl of curcumin stock solution and
incubated for 30 min at room temperature.
Electron microscopy. The samples were prepared for electron
microscopy and imaged as described elsewhere (18). Briefly, after
fixation with 2% paraformaldehyde, the samples were stained with 2%
neutral uranyl acetate and further stained and embedded in uranyl acetate
and methyl cellulose mixture (1.8/0.4%). The samples were viewed
using a JEOL JEM-1400 (JEOL Ltd, Tokyo, Japan) transmission
electron microscope operating at 80 kV. Images were taken with a Gatan
Orius SC 1000B CCD-camera (Gatan Inc., Pleasanton, CA, USA) with
4008×2672 pixel image size and no binning.
The morphology of the EVs (50-125 nm) before and after adding
curcumin was confirmed by electron microscopy (Figure 1).
Cell culture. Two human OTSCC cell lines, HSC-3 (Japan Health
Sciences Foundation, Tokyo, Japan) and SCC-25 (American Type
Culture Collection, Manassas, VA, USA) were used in this study.
HSC-3 is a highly invasive cell line, while SCC-25 is less invasive
(19). The cells were cultured in 75 cm2 flasks containing Dulbecco’s
modified Eagle’s medium (DMEM)-12 (Gibco, Paisley, UK) supplied
with 10% heat-inactivated foetal bovine serum, 100 U/ml penicillin,
100 μg/ml streptomycin, 250 ng/ml amphotericin B, 0.4 μg/ml
hydrocortisone and 50 μg/ml ascorbic acid.
Proliferation assay. Cell proliferation assay was performed using a Cell
Proliferation enzyme-linked immunosorbent assay (ELISA), 5-bromo-
2’-deoxyuridine BrdU (colorimetric) Kit (Roche, Mannheim, Germany)
according to the manufacturer’s instructions. Briefly, the cells were
cultured in 96-well plates at a density of 5×103 cells/200 μl and
exposed to FLJ (500, 2,500, or 5,000 μg/ml), curcumin (25, 125, or 250
μg), or curcumin-loaded EVs (25, 125, or 250 μg); phosphate-buffered
saline was used as a control. After 48 h, the cells were labelled using
10 μM BrdU per well and re-incubated for 2 h at 37˚C in a humidified
atmosphere. The culture medium was removed, the cells were fixed,
and the DNA was denatured in one step by adding FixDenat. Next, the
cells were incubated with anti-BrdU-POD for 90 min at room
temperature. After the removal of the antibody conjugate, the cells were
washed, and the substrate solution was added. The reaction product was
quantified by measuring the absorbance using a scanning multi-well
spectrophotometer (Thermo Scientific Multiskan EX, Thermo Fisher
Scientific, MA, USA) at 450 nm with a reference wavelength of 690
nm. The results are expressed as mean absorbance values.
Three-dimensional (3D) tumour Myogel spheroid invasion assay.
Cells were added (1000 cells per well) into a Corning™ ultra-low
attachment 96-well round bottom plate (Costar® Corning Inc.,
Kennebunk, ME, USA). The plate was transferred to an incubator
(37˚C, 5% carbon dioxide, 95% humidity). After 4 days, tumour
spheroid formation was visually confirmed.
One hundred microlitres of growth medium was removed from
each well and replaced by 100 μl of a mixture of Myogel (0.5 mg/ml)
and collagen I (0.5 mg/ml; BD Biosciences, Bedford, MA, USA)
cFLJ (500, 2500, or 5,000 μg/ml), curcumin (25, 125, or 250 μg), or
curcumin-loaded EVs (25, 125, or 250 μg). The plate was transferred
to an incubator at 37˚C and the Myogel–collagen mixture was
allowed to solidify. After 1 h, 100 μl/well of complete growth
medium plus FLJ, curcumin or EVs loaded with curcumin at the same
concentration was added. Images were taken at 0, 24, 48, 72 and 
96 h using a Nikon DS-Fi2 camera (Nikon, Tokyo, Japan) with 
4× magnification (light microscope, no phase contrast). The spheroid
diameter (Figure 2, indicated by the solid arrow) and cell invasion
(Figure 2, indicated by the dashed arrow) were measured using
ImageJ 1.50i (Wayne Rasband, National Institute of Mental Health,
Bethesda, MD, USA).
Statistical analysis. All experiments were repeated three times
independently, each in triplicate. Values are given as mean±standard
deviation. To determine the statistical significance, a one-way
analysis of variance (ANOVA) followed by a Bonferroni post-hoc
test was performed. Statistical significance was set at p<0.05. All
statistical analyses were performed using IBM SPSS Statistics
version 24.0 (IBM Corp., Armonk, NY, USA).
Results
FLJ and curcumin inhibited proliferation of OTSCC cells.
Exposing the HSC-3 cells to FLJ inhibited cell proliferation
at concentrations of 2.5 and 5.0 mg/ml (Figure 3A).
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Curcumin with and without Candida EVs acted similarly but
at lower concentrations (125 and 250 μg/ml; Figure 3B and
C). The half maximal-inhibitory concentration (IC50) for FLJ
was 1162 μg/ml, and was 35 μg/ml for curcumin.
SCC-25 cell proliferation, similarIy to HSC-3, was
inhibited by FLJ and curcumin with and without EVs (Figure
3A-C) at concentrations of 2.5 mg/ml or more for FLJ and 125
μg/ml or more for curcumin. The IC50 was 773 μg/ml for FLJ
and 25 μg/ml for curcumin. This demonstrates that the less
aggressive SCC-25 cells were more sensitive to FLJ and
curcumin than the more aggressive HSC-3 cells.
The anti-proliferative effects on HSC-3 and SCC-25 cells
were statistical significant for FLJ (p=0.023 and p=0.001,
respectively) and curcumin (p=0.00003 and p=0.002,
respectively).
FLJ and curcumin significantly reduced the invasion of
OTSCC cells in the 3D Myogel spheroid assay without
affecting spheroid size. Exposing the 3D Myogel spheroids
of OTSCC cells to curcumin with and without EVs and FLJ
for 96 h did not change the spheroid size (data not shown).
For HSC-3 cells, the spheroid diameter was 200-250 μm and
for SCC-25 cells 150-200 μm.
The invasion of HSC-3 cells was significantly inhibited
by FLJ (p=0.000009; Figure 4A and B), curcumin (p=0.001;
Figure 4C and D), and curcumin-loaded EVs (p=0.000125;
Figure 4E and F). FLJ (Figure 5A and B), curcumin
(p=0.034; Figure 5C and D), curcumin-loaded EVs
(p=0.028; Figure 5E and F) inhibited SCC-25 cell invasion
at concentrations similar to those against HSC-3, but for FLJ
the effect was not statistically significant. The statistical
significance was calculated based on the area under the curve
of the invading cancer cells over time. 
Discussion
Our in vitro study showed anti-proliferative and anti-invasive
effects of FLJ on more (HSC-3) and less (SCC-25)
aggressive OTSCC cell lines similarly to curcumin.
However, the IC50 of curcumin was approximately 30-times
lower than that of FLJ in both cell lines tested.
The inhibition of OTSCC cell proliferation by FLJ is
similar to the results obtained by Brown et al. (20) using a
highly invasive human colorectal adenocarcinoma cell line,
HT115. The anti-proliferative effects of lingonberry were
also demonstrated in human cervical (HeLa) and colon
(Caco-2) cancer cells (21).
Curcumin inhibited OTSCC proliferation and invasion in
both cell lines similarly to the study by Lee et al. (11) in
which they also analysed SCC-25 cells. In that study,
proliferation was measured by trypan blue and invasion in the
transwell assay, while in the present study a BrdU Kit and 3D
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Figure 1. Morphology and size of extracellular vesicles (EVs). An electron microscope was used to confirm the presence of the EVs before (A) and
after (B) adding curcumin.
Figure 2. The three-dimensional Myogel spheroid assay. Spheroid
diameter (solid arrow) and cell invasion (dashed arrow) were measured
using the ImageJ 1.50i software.
spheroid assay, respectively, were used. In addition, in their
experiments, a concentration as low as 10 μM curcumin
reduced cell invasion by 95%, and 15 μM curcumin reduced
cell viability by 50%. In our experiments, the IC50 of
curcumin for SCC-25 cell proliferation was 25 μM.
Our attempt to increase curcumin bioavailability by
mixing curcumin with Candida EVs did not show similar
additive effects to those in the study by Aqil et al. (16),
which used EVs from raw bovine milk. The EVs isolated
from milk were mixed with curcumin and those curcumin-
loaded EVs were able to inhibit the proliferation of lung
(A549 and H1299), cervical (CaSki and HeLa) and breast
cancer (MDA-MB-231 and T47D) cell lines more efficiently
than curcumin itself. In our study, the EVs isolated from C.
glabrata G212 did not affect cell proliferation; after the EVs
were loaded with curcumin, the effects were similar to those
of curcumin alone on OTSCC cell proliferation and
invasion. One explanation could be that bovine milk EVs
may take up more curcumin compared with Candida EVs.
The amount of curcumin in different EV isolations may vary
and should be compared. It would be interesting to analyse
whether raw cow milk EVs mixed with curcumin would
have different effects on the invasion and proliferation of
OTSCC cells than EVs from other sources, such as Candida
or saliva (22).
Berries from the genus Vaccinium have been tested in
some anticancer studies as described in a review article by
Neto (23). However, so far, only the effect of blueberry
powder has been analysed on oral carcinogenesis in a
hamster model, where it inhibited both cancer invasion and
angiogenesis (24). The bioactive compounds of lingonberry
in vitro were shown to be similar before and after
fermentation, and degradation (20). The variety of
anthocyanin metabolites after ingesting another Vaccinium,
chokeberry, included at least 10 individual anthocyanin
metabolites found in urine and serum (25). The concentration
of anthocyanins detected in plasma was 138 nmol/l derived
from 1435 μmol ingested from bilberries and lingonberries
(26). The concentration of curcumin detected in serum after
ingesting 4 g per day was on average 0.51±0.11 μM, after 6
g it was 0.63±0.06 μM and after 8 g it was 1.77±1.87 μM
(12). The concentration of curcumin which inhibited the
proliferation and invasion of OTSCC cells was 30 times
lower than that required for FLJ. However, a person is
undoubtedly able to consume high amounts (more than 
100 g) of berries daily, whereas consuming the required daily
amount of curcumin is less noticeable. Therefore, the anti-
carcinogenic effects for both compounds could easily, at least
in theory, be ingested on a daily basis.
In conclusion, our study showed that FLJ significantly
inhibited the invasion and proliferation of OTSCC cells, but
the concentration needs to be higher than that of curcumin.
Loading curcumin into Candida EVs improved its poor
in vivo 32: 1089-1095 (2018)
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Figure 3. Inhibition of HSC-3 and SCC-25 cell proliferation after 48 h of
exposure to fermented lingonberry juice (FLJ), curcumin and curcumin-
loaded extracellular vesicles (EVs). A colorimetric proliferation assay
was used to study the effects of FLJ (A), curcumin (B) and curcumin-
loaded EVs (C) on oral tongue squamous cell carcinoma. PBS was used
as control. Statistical significance was determined using one-way ANOVA
followed by a Bonferroni post-hoc test. All experiments were repeated
independently three times and each in triplicate. Results are the means of
the three replicate experiments±standard error. Significantly different at
*p≤0.05, **p≤0.01, ***p≤0.001, and ****p≤0.0001.
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Figure 4. Effects of fermented lingonberry juice (FLJ) and curcumin on the invasiveness of HSC-3 cells after 96 h of exposure. The three-dimensional
tumour spheroid invasion assay was used to study the effects of FLJ (A), curcumin (C) and curcumin-loaded extracellular vesicles (E) on oral
tongue squamous cell carcinoma invasion. Phosphate-buffered solution was used as control. Invasion was measured using the ImageJ software. All
experiments were repeated independently three times and each in triplicate, except for FLJ, which was performed twice in triplicate. Results are
the means±standard error. Statistical significance was determined by calculating the area under the curve of the invading cancer cells over time,
and using one-way ANOVA followed by a Bonferroni post-hoc test. Significantly different at ***p≤0.001 and ****p≤0.0001.
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Figure 5. Effects of fermented lingonberry juice (FLJ) and curcumin on the invasiveness of SCC-25 cells after 96 h of exposure. The three-
dimensional tumour spheroid invasion assay was used to study the effects of FLJ (A), curcumin (B) and curcumin-loaded extracellular vesicles (C)
on OTSCC invasion. Invasion was measured using the ImageJ software. All experiments were repeated independently three times and each in
triplicate. Results are the means±standard error. Statistical significance was determined by calculating the area under the curve and using one-
way ANOVA followed by a Bonferroni post-hoc test. Significantly different at *p≤0.05.
bioavailability, but the anti-carcinogenic effect on OTSCC
cells was unchanged. In vivo animal studies of FLJ
compounds should be conducted to see whether it is able to
prevent or reduce the progression of OTSCC.
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